Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 3,350.00
+35.00 (1.06%)
Sep 18, 2026, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 43.25 billion as of September 17, 2026. Its market cap has decreased by -64.68% in one year.
Market Cap
43.25B
Enterprise Value
27.02B
Revenue
395.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,350.00
ChartMarket Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 43.25B, a decrease of -59.29%. That is a compound annual growth rate of -40.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 43.25B | -62.47% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genexine | 127.57B |
| Vaxcell-Bio Therapeutics | 100.59B |
| MedPacto | 93.91B |
| iNtRON Biotechnology | 88.35B |
| Prestige BioPharma | 71.63B |
| Amicogen | 58.69B |
| ENCell | 58.68B |
| ORIENT BIO | 54.13B |